What Vetgenomics does

Vetgenomics (legal entity: VETGENOMICS, S.L.) is a privately held Spanish limited company founded in 2011 as the first technology-based company (EBT) spin-off from the Universitat Autònoma de Barcelona (UAB). The company operates from the Parc de Recerca de la UAB in Bellaterra, Cerdanyola, Barcelona, and delivers genetic and genomic testing services to two distinct segments: (1) veterinary clinicians and pet owners, offering clinical genetic diagnostics such as pathogen detection by real-time PCR (including species-level identification and Leishmania parasite load quantification), hereditary disease screening (MDR1 in collies/sheepdogs, PKD in Persian cats), and bird sexing/raptor identification from non-invasive samples including eggshells; and (2) companies, research centers, and universities, which receive on-demand custom genetic assay design, development, optimization, validation, and technology transfer, plus metagenomic sequencing and bioinformatic analysis through a One Health lens.

The underlying technology stack combines classical PCR, real-time PCR, fragment analysis, genotyping, Sanger sequencing, and metagenomic sequencing on portable devices. The lab is ISO 9001:2015 certified (UKAS-accredited), holds the Spanish "Pyme innovadora" (Innovative SME) designation, and was granted MITECO certification in 2024. Vetgenomics retains extracted DNA from client samples for two years, enabling repeat analytics. It has spawned two affiliated ventures: Nano1Health (metagenomics for One Health applications, including pathogen and antimicrobial resistance biomarker characterization) and Can-Identification (a canine identification system spun off in July 2025 to address dog waste on public roads).

The business model is professional services-led with quote-based pricing that is not publicly disclosed. Revenue streams include fee-for-service genetic testing for veterinary clinics and pet owners (one-off per sample), custom R&D services for enterprise/academic clients, and metagenomic services routed through Nano1Health. The go-to-market is sales-led and direct: personalized customer engagement through the website, downloadable sample submission forms, WhatsApp (663 882 486), and phone (+34 935 630 711), with LinkedIn as the primary social channel. Geographic scope is currently Spain-domestic (with Europe noted as market served), with no disclosed e-commerce or self-serve platform.

Name

Vetgenomics

Legal name

VETGENOMICS, S.L.

Website

https://vetgenomics.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Vetgenomics is a Barcelona-based veterinary genomics laboratory spun out of the Universitat Autònoma de Barcelona that provides clinical genetic diagnostics (pathogen detection, hereditary disease screening, bird sexing) to veterinarians and pet owners, and custom genomic assay development and metagenomics services to companies, research centers, and universities.

Ownership category

akta.pro rank

Product category

Veterinary Genetic Diagnostics

NAICS

Medical Laboratories (621511), Veterinary Services (54194)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular & Genetic Testing (Breed, Hereditary Disease, Oncology) (HLAMADAE)

Keywords

• Veterinary genetic diagnostics
• Molecular diagnostics services
• Animal genomics testing
• Pathogen detection PCR
• Metagenomic sequencing

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Genetic diagnostic testing services: Vetgenomics provides genetic analysis services for clinical diagnosis, including pathogen detection, hereditary disease testing, and bird sexing. Services are offered both to veterinary professionals and pet owners, as well as to companies, research centers, and universities on an on-demand basis. Pricing is quote-based and not publicly disclosed.
2. On-demand research and development services: Custom assay design, development, optimization, and validation services for companies, research centers, and universities, including large-scale pathogen testing, species identification, and mutation discovery.
3. Metagenomics services: Metagenomic sequencing and bioinformatic analysis services provided through Nano1Health, applying genomics and bioinformatics technologies from a One Health perspective.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Vetgenomics provides applied genomic diagnostic services for veterinary medicine and animal health. Its core offerings include real-time PCR pathogen detection with species-level sequencing (specialized in vector-borne diseases and Leishmania load quantification), hereditary disease mutation screening (MDR1, PKD), molecular bird sexing and raptor identification, and metagenomic sequencing with bioinformatic analysis from a One Health perspective. Services are delivered to veterinary clinicians, pet owners, companies, research centers, and universities, with custom assay design, development, optimization, validation, and technology transfer available on demand.

Product overview

Vetgenomics offers a portfolio of genomic services organized around two main client segments: (1) Services on Demand for companies, research centers, and universities, covering custom assay design, development, optimization, validation, and transfer, plus metagenomics; and (2) Genetic Analysis for clinical veterinary diagnosis serving veterinarians and pet owners, encompassing pathogen detection by real-time PCR, hereditary disease screening (MDR1, PKD), and bird sexing/raptor identification. The company is the first technology-based company (EBT) of the Universitat Autònoma de Barcelona, founded in 2011.

Differentiator

Problem solved

Functional benefit

Brands

• Can-ID: Innovative canine identification system created to address dog waste on public roads. This initiative led to the creation of Can-Identification, which has been operating independently since July 2025.

Products and services

• Services on Demand (Custom Assay Development) Specialized genetic testing services for companies, research centers, and universities covering design, development, optimization, validation, and technology transfer of new genetic diagnostic assays, including large-scale pathogen testing, species identification across various sample matrices, and regulatory-compliance procedure validation.
• Genetic Analysis for Clinical Diagnosis Genetic analysis services for veterinary clinical diagnosis, including pathogen detection by real-time PCR, hereditary disease screening (MDR1, PKD), and bird sexing for pets and birds of prey, offered to veterinary clinicians and pet owners.
• Metagenomics Service Metagenomic sequencing on portable devices with aggregated bioinformatic analysis from a One Health perspective covering human, animal, and environmental health, including identification and characterization of microorganisms, pathogens, and drug resistance biomarkers.

Quantifiable outcome

• Species-level pathogen detection enables identification of emerging or localized pathogens not previously found in specific animal species
• +3 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

Three partnerships are on record, tiered major spin-off and core.

• Nano1Healthmajor spin-offOthers · 1 July 2025Nano1Health is a company established by Vetgenomics following extensive metagenomics research. It applies advanced genomics and bioinformatics technologies for the identification and characterization of microorganisms, pathogens, and drug resistance biomarkers from a One Health perspective. Nano1Health operates independently and shares a logo and close association with Vetgenomics on the parent company website.
• Can-Identificationmajor spin-offOthers · 1 July 2025Can-Identification was established as an independent company in July 2025, originating from Vetgenomics' development of the Can-ID canine identification system. Can-ID was an innovative canine identification system created to address dog waste on public roads. The company now operates independently.
• Universitat Autònoma de Barcelona (UAB)coreStrategic or Co-development PartnerVetgenomics is the first technology-based company (EBT) of UAB, established with academics and researchers from the university. The company maintains a close relationship with UAB, operating from the Parc de Recerca de la UAB research park. UAB is listed as a partner on the Vetgenomics website.

Scale indicators4 records

Recent moves2 records

Broad incumbents

• Antech Diagnostics: Mars Petcare-owned veterinary reference laboratory network in North America providing PCR, genetic and clinical diagnostics to clinics. Comparable scaled reference-lab competitor pursuing similar send-out testing relationships with veterinarians.
• Neogen Corporation: Animal safety and genomics company offering genomic testing services and diagnostics for livestock, companion animals and food safety. Comparable as a larger incumbent with overlapping molecular-testing and One Health ambitions similar to Vetgenomics' metagenomics via Nano1Health.
• Wisdom Panel: Mars Petcare-owned pet DNA testing brand covering breed, health and trait screening for dogs and cats. Comparable as a scaled, branded consumer genetic-testing competitor to Vetgenomics' clinical hereditary panel offerings.
• IDEXXX Laboratories: Global leader in veterinary diagnostics and reference laboratory services for companion and livestock animals. Comparable as the dominant scaled veterinary reference-lab competitor that Vetgenomics' PCR and genetic-testing services compete against for clinic send-outs across Europe.

Direct peers

• Embark Veterinary: US-based DTC canine genetic testing company offering breed identification, health and hereditary disease screening. Directly comparable to Vetgenomics' dog-owner-facing hereditary disease and paternity testing services.
• Basepaws (Zoetis): Zoetis-owned feline and canine genetic testing brand offering breed and health screening. Comparable as a DTC-adjacent pet genetic-testing service competing for the same veterinary and pet-owner demand Vetgenomics serves.

Regional players

• Royal GD (Gezondheidsdienst voor Dieren): Dutch animal health laboratory offering veterinary diagnostics, genomics and disease monitoring for livestock and companion animals. Comparable as a European veterinary reference lab with PCR/infectious-disease testing overlap, though stronger focus on production animals.
• Laboklin: Germany-headquartered independent veterinary diagnostic laboratory offering PCR, genetic and clinical pathology testing across Europe. Closest regional peer to Vetgenomics — same niche (veterinary molecular diagnostics) in adjacent European markets.
• Genera (Genomedia): Brazil-based veterinary molecular diagnostics and genetic testing laboratory operating in South America. Comparable operating model (academic-rooted veterinary molecular diagnostics lab) though geographically distinct.

Others

• CVRL (Central Veterinary Research Laboratory): Commercial veterinary diagnostic laboratory providing PCR, serology and reference services. Comparable as a veterinary-focused contract diagnostics lab in the broader European ecosystem where scale players dominate.

Market position

Strengths4 records

Weaknesses4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/vetgenomics
• Xx.com/VetgenomicsNews

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vetgenomics